Results 201 to 210 of about 478,848 (342)

Metabolic dysfunction impairs Mycobacterium tuberculosis-specific cytokine and chemokine responses in latent tuberculosis and type 2 diabetes mellitus. [PDF]

Sci Rep
Ssekamatte P, Sitenda D, Nabatanzi R, Nkurunungi G, Nakibuule M, Kibirige D, Kyazze AP, Kateete DP, Bagaya BS, Sande OJ, van Crevel R, Cose S, Biraro IA.   +12 more
europepmc   +1 more source

Chemokines: signal lamps for trafficking of T and B cells for development and effector function

, 1999
Chang H. Kim, Hal E. Broxmeyer
openalex   +1 more source

Chemokine and inflammatory cytokine changes during chronic wound healing [PDF]

, 1997
David Fivenson, Duyen T. Faria, Brian J. Nickoloff, Peter J. Poverini, Steven L. Kunkel, Marie D. Burdick, Robert M. Strieter   +6 more
openalex   +1 more source

Chemokines and Glycosaminoglycans [PDF]

Frontiers in Immunology, 2015
openaire   +4 more sources

Mitochondrial Transplantation via Magnetically Responsive Artificial Cells Promotes Intracerebral Hemorrhage Recovery by Supporting Microglia Immunological Homeostasis

Advanced Materials, Volume 37, Issue 13, April 2, 2025.
A type of magnetically responsive artificial cells (ACs) has been developed, demonstrating the loading of mitochondria and self‐enclosure processes to ensure the protection of mitochondrial transport via the bloodstream. The treatment with ACs effectively transplanted mitochondria around the lesion, thereby improving neurological recovery by supporting
Mi Zhou, Jinhui Zang, Yuxuan Qian, Qiang Zhang, Yifan Wang, Tingting Yao, Hongyu Yan, Kai Zhang, Xiaojun Cai, Lixian Jiang, Yuanyi Zheng   +10 more
wiley   +1 more source

Unraveling the role of chemokines in cutaneous T-cell lymphoma: expression levels at different stages. [PDF]

Front Immunol
Guglielmo A, Zengarini C, Tugnoli F, Zinzani PL, Borghi A, Corazza M, La Placa M, Piraccini BM, Pileri A.   +8 more
europepmc   +1 more source

Engineering CRISPR System‐Based Bacterial Outer Membrane Vesicle Potentiates T Cell Immunity for Enhanced Cancer Immunotherapy

Advanced Materials, EarlyView.
This study develops a multifunctional CRISPR‐dCas9‐based OMV platform termed OMV‐C9I12, which facilitates the coexpression of CXCL9 and IL‐12 within tumor cells. This platform enhances T cell recruitment and activation, synergizes with anti‐PD‐1/PD‐L1 immunotherapy, and amplifies antitumor T cell immunity.
Hongjin Wang, Hengji Zhan, Bolin Pan, Leli Zeng, Zehua Chen, Sen Liu, Qiang Zhang, Xuwei Hong, Junlin Lu, Xinrou Lin, Xiao Zhao, Jiajian Lai, Kaiwen Jie, Ye Li, Jianmei Zhong, Shengmeng Peng, Siting Chen, Changhao Chen, Wenlong Zhong, Shaoxu Wu, Yihang Pan, Tianxin Lin, Xu Chen   +22 more
wiley   +1 more source

Core signature of rejection-associated cytokines and chemokines in endomyocardial biopsies after heart transplantation. [PDF]

Front Cardiovasc Med
Radomsky LM, Kühne JF, Beushausen K, Keil J, Knigina L, Scheibner Y, Görler A, Ruhparwar A, Ius F, Bara CL, Falk CS.   +10 more
europepmc   +1 more source

Effect of JAK inhibitors on release of CXCL9, CXCL10 and CXCL11 from human airway epithelial cells [PDF]

, 2015
Barnes, PJ, Donnelly, LE, Fenwick, PS, Macedo, P   +3 more
core   +1 more source

Regulation of cytokine expression and leukotriene formation in human basophils by growth factors, chemokines and chemotactic agonists [PDF]

, 1999
B Ochensberger, Lorenz Tassera, Delphine Bifrare, Silvia Rihs, Clemens A. Dahinden   +4 more
openalex   +1 more source